Wong S, Bryan L
Departments of Microbiology and Infectious Diseases, University of Calgary and Foothills Hospital, Calgary, Alberta.
Can J Infect Dis. 1990 Summer;1(2):51-6. doi: 10.1155/1990/258273.
Trospectomycin, unlike aminoglycosidic aminocyclitols, is accumulated by a nonsaturable, energy-independent, diffusional process in Salmonella typhimurium, Escherichia coli and Haemophilus influenzae. A deep rough mutant of S typhimurium was more susceptible and accumulated the drug faster, and F porin deficient mutants of E coli were more resistant than parental strains. Trospectomycin likely uses both porin and nonporin pathways to cross the outer membrane. An E coli strain effectively accumulated the drug anaerobically, explaining its anaerobic activity. An H influenzae strain accumulated trospectomycin at concentrations below those for which detectable uptake could be observed with E coli or S typhimurium strains, consistent with greater activity in Haemophilus species.
与氨基糖苷类氨基环醇不同,壮观霉素在鼠伤寒沙门氏菌、大肠杆菌和流感嗜血杆菌中通过一种非饱和、不依赖能量的扩散过程进行积累。鼠伤寒沙门氏菌的深粗糙突变体更易感染且积累药物更快,而大肠杆菌的F孔蛋白缺陷突变体比亲本菌株更具抗性。壮观霉素可能同时利用孔蛋白和非孔蛋白途径穿过外膜。一株大肠杆菌菌株在厌氧条件下能有效积累该药物,这解释了其厌氧活性。一株流感嗜血杆菌菌株在低于大肠杆菌或鼠伤寒沙门氏菌菌株可观察到可检测摄取浓度的情况下积累壮观霉素,这与该药物在嗜血杆菌属中具有更高活性一致。